Patsy G. Oliver

1.9k total citations
35 papers, 1.5k citations indexed

About

Patsy G. Oliver is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Patsy G. Oliver has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Patsy G. Oliver's work include Cell death mechanisms and regulation (12 papers), Cancer Research and Treatments (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Patsy G. Oliver is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Cancer Research and Treatments (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Patsy G. Oliver collaborates with scholars based in United States, France and Canada. Patsy G. Oliver's co-authors include Donald J. Buchsbaum, William E. Grizzle, Albert F. LoBuglio, Tong Zhou, Robert P. Kimberly, Sharmila Makhija, Toshiaki Ohtsuka, Wenquan Wang, Tong Zhou and Kurt R. Zinn and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Patsy G. Oliver

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patsy G. Oliver United States	22	1.1k	509	308	290	133	35	1.5k
Cameron N. Johnstone Australia	24	1.1k 1.0×	555 1.1×	445 1.4×	324 1.1×	109 0.8×	38	1.7k
Shiv K. Gupta United States	24	1.1k 1.0×	483 0.9×	292 0.9×	148 0.5×	104 0.8×	56	1.7k
Sharon Yee United States	16	1.3k 1.2×	635 1.2×	295 1.0×	515 1.8×	120 0.9×	22	1.8k
Jianhua Ling United States	22	1.2k 1.1×	594 1.2×	457 1.5×	402 1.4×	114 0.9×	28	1.8k
Jean Gudas United States	25	1.3k 1.1×	945 1.9×	404 1.3×	345 1.2×	161 1.2×	44	2.1k
Vimla Band United States	17	1.1k 1.0×	618 1.2×	351 1.1×	126 0.4×	186 1.4×	23	1.7k
Yusuke Nakamura Japan	24	1.2k 1.1×	457 0.9×	308 1.0×	146 0.5×	140 1.1×	38	1.8k
Csaba Mahotka Germany	22	1.4k 1.3×	517 1.0×	220 0.7×	350 1.2×	126 0.9×	46	1.7k
Weili Ma Taiwan	16	1.3k 1.2×	986 1.9×	348 1.1×	186 0.6×	149 1.1×	59	2.0k
Jeong Heon Ko South Korea	20	1.2k 1.1×	371 0.7×	171 0.6×	589 2.0×	152 1.1×	41	1.6k

Countries citing papers authored by Patsy G. Oliver

Since Specialization

Citations

This map shows the geographic impact of Patsy G. Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patsy G. Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patsy G. Oliver more than expected).

Fields of papers citing papers by Patsy G. Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patsy G. Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patsy G. Oliver. The network helps show where Patsy G. Oliver may publish in the future.

Co-authorship network of co-authors of Patsy G. Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of Patsy G. Oliver. A scholar is included among the top collaborators of Patsy G. Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patsy G. Oliver. Patsy G. Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graham, James M., Katrin P. Guillen, Patsy G. Oliver, et al.. (2020). STAT3 and GR Cooperate to Drive Gene Expression and Growth of Basal-Like Triple-Negative Breast Cancer. Cancer Research. 80(20). 4355–4370. 22 indexed citations

Agarwal, Sumit, Balabhadrapatruni V. S. K. Chakravarthi, Hyung‐Gyoon Kim, et al.. (2020). PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression. Translational Oncology. 13(7). 100776–100776. 21 indexed citations

Pathak, Vibha, Corinne E. Augelli‐Szafran, Han‐Xun Wei, et al.. (2018). Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 19(5). 1524–1524. 38 indexed citations

Oliver, Patsy G., et al.. (2018). Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease Modeling. Advances in experimental medicine and biology. 1077. 87–113. 3 indexed citations

Landen, Charles N., Rebecca C. Arend, Ashwini A. Katre, et al.. (2018). FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer. Cancer Letters. 436. 75–86. 17 indexed citations

Chakraborty, Asmi, Kaitlyn A. Dorsett, Hoa Q. Trummell, et al.. (2017). ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. Journal of Biological Chemistry. 293(3). 984–994. 72 indexed citations

Smith, Matthew Ryan, Praveen K. Vayalil, Fen Zhou, et al.. (2016). Mitochondrial thiol modification by a targeted electrophile inhibits metabolism in breast adenocarcinoma cells by inhibiting enzyme activity and protein levels. Redox Biology. 8. 136–148. 13 indexed citations

Varley, Katherine E., Jason Gertz, Brian S. Roberts, et al.. (2014). Recurrent read-through fusion transcripts in breast cancer. Breast Cancer Research and Treatment. 146(2). 287–297. 128 indexed citations

Londoño-Joshi, Angelina I., Patsy G. Oliver, Yufeng Li, et al.. (2011). Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity. Breast Cancer Research and Treatment. 133(2). 437–445. 20 indexed citations

10.

Oliver, Patsy G., Albert F. LoBuglio, Tong Zhou, et al.. (2011). Effect of anti-DR5 and chemotherapy on basal-like breast cancer. Breast Cancer Research and Treatment. 133(2). 417–426. 30 indexed citations

11.

Oliver, Patsy G., Albert F. LoBuglio, Kurt R. Zinn, et al.. (2008). Treatment of Human Colon Cancer Xenografts with TRA-8 Anti-death Receptor 5 Antibody Alone or in Combination with CPT-11. Clinical Cancer Research. 14(7). 2180–2189. 30 indexed citations

12.

Fiveash, John B., et al.. (2008). Enhancement of Glioma Radiotherapy and Chemotherapy Response With Targeted Antibody Therapy Against Death Receptor 5. International Journal of Radiation Oncology*Biology*Physics. 71(2). 507–516. 23 indexed citations

13.

Vickers, Selwyn M., Kurt R. Zinn, Zhi Huang, et al.. (2007). TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth. Molecular Cancer Therapeutics. 6(12). 3198–3207. 39 indexed citations

14.

Estes, Jacob M., Patsy G. Oliver, J. Michael Straughn, et al.. (2007). Efficacy of anti-death receptor 5 (DR5) antibody (TRA-8) against primary human ovarian carcinoma using a novel ex vivo tissue slice model. Gynecologic Oncology. 105(2). 291–298. 38 indexed citations

15.

Kamradt, Merideth C., Meiling Lü, Michael E. Werner, et al.. (2005). The Small Heat Shock Protein αB-crystallin Is a Novel Inhibitor of TRAIL-induced Apoptosis That Suppresses the Activation of Caspase-3. Journal of Biological Chemistry. 280(12). 11059–11066. 181 indexed citations

16.

Straughn, J. Michael, Patsy G. Oliver, Tong Zhou, et al.. (2005). Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model. Gynecologic Oncology. 101(1). 46–54. 41 indexed citations

17.

Ohtsuka, Toshiaki, Donald J. Buchsbaum, Patsy G. Oliver, et al.. (2003). Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene. 22(13). 2034–2044. 138 indexed citations

18.

Wang, Hui, Patsy G. Oliver, Zhuo Zhang, Sudhir Agrawal, & Ruiwen Zhang. (2003). Chemosensitization and Radiosensitization of Human Cancer by Antisense Anti‐MDM2 Oligonucleotides. Annals of the New York Academy of Sciences. 1002(1). 217–235. 45 indexed citations

19.

Buchsbaum, Donald J., et al.. (2002). Treatment of human breast cancer xenografts with monoclonal antibody against DR5 with or without chemotherapy inhibits tumor growth in nude mice. 43. 1005–1006. 2 indexed citations

20.

Wang, Hui, Patsy G. Oliver, Nan Li, et al.. (2002). Radiolabeled 2′-fluorodeoxyuracil-β- D -arabinofuranoside (FAU) and 2′-fluoro-5-methyldeoxyuracil-β -D -arabinofuranoside (FMAU) as tumor-imaging agents in mice. Cancer Chemotherapy and Pharmacology. 49(5). 419–424. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact